Receptor Usage and Cell Entry of Bat Coronavirus HKU4 Provide Insight into Bat-to-human Transmission of MERS Coronavirus

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2014 Aug 13

PMID 25114257

Citations 186

Authors

Yang Yang

Lanying Du

Chang Liu

Lili Wang

Cuiqing Ma

Jian Tang

Ralph S Baric

Shibo Jiang

Fang Li

Affiliations

Soon will be listed here.

Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) currently spreads in humans and causes ∼ 36% fatality in infected patients. Believed to have originated from bats, MERS-CoV is genetically related to bat coronaviruses HKU4 and HKU5. To understand how bat coronaviruses transmit to humans, we investigated the receptor usage and cell entry activity of the virus-surface spike proteins of HKU4 and HKU5. We found that dipeptidyl peptidase 4 (DPP4), the receptor for MERS-CoV, is also the receptor for HKU4, but not HKU5. Despite sharing a common receptor, MERS-CoV and HKU4 spikes demonstrated functional differences. First, whereas MERS-CoV prefers human DPP4 over bat DPP4 as its receptor, HKU4 shows the opposite trend. Second, in the absence of exogenous proteases, both MERS-CoV and HKU4 spikes mediate pseudovirus entry into bat cells, whereas only MERS-CoV spike, but not HKU4 spike, mediates pseudovirus entry into human cells. Thus, MERS-CoV, but not HKU4, has adapted to use human DPP4 and human cellular proteases for efficient human cell entry, contributing to the enhanced pathogenesis of MERS-CoV in humans. These results establish DPP4 as a functional receptor for HKU4 and host cellular proteases as a host range determinant for HKU4. They also suggest that DPP4-recognizing bat coronaviruses threaten human health because of their spikes' capability to adapt to human cells for cross-species transmissions.

Citing Articles

ACE2 utilization of HKU25 clade MERS-related coronaviruses with broad geographic distribution.

Liu C, Park Y, Ma C, Stuart C, Gen R, Sun Y bioRxiv. 2025; .

PMID: 40027745 PMC: 11870458. DOI: 10.1101/2025.02.19.639017.

Origin and cross-species transmission of bat coronaviruses in China.

Latinne A, Hu B, Olival K, Zhu G, Zhang L, Li H Nat Commun. 2024; 15(1):10705.

PMID: 39702450 PMC: 11659393. DOI: 10.1038/s41467-024-55384-7.

Viral susceptibility and innate immune competency of bat cells produced for virological studies.

Gonzalez V, Word C, Guerra-Pilaquinga N, Mazinani M, Fawcett S, Portfors C bioRxiv. 2024; .

PMID: 39605657 PMC: 11601607. DOI: 10.1101/2024.11.19.624190.

Distinct pathways for evolution of enhanced receptor binding and cell entry in SARS-like bat coronaviruses.

Tse A, Acreman C, Ricardo-Lax I, Berrigan J, Lasso G, Balogun T PLoS Pathog. 2024; 20(11):e1012704.

PMID: 39546542 PMC: 11602109. DOI: 10.1371/journal.ppat.1012704.

Identification of the critical residues of TMPRSS2 for entry and host range of human coronavirus HKU1.

Chen Y, Ou X, Li P, Zan F, Tan L, Qian Z J Virol. 2024; 98(12):e0158724.

PMID: 39526774 PMC: 11650973. DOI: 10.1128/jvi.01587-24.

References

Reusken C, Haagmans B, Muller M, Gutierrez C, Godeke G, Meyer B . Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis. 2013; 13(10):859-66. PMC: 7106530. DOI: 10.1016/S1473-3099(13)70164-6. View

de Groot R, Baker S, Baric R, Brown C, Drosten C, Enjuanes L . Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol. 2013; 87(14):7790-2. PMC: 3700179. DOI: 10.1128/JVI.01244-13. View

Simmons G, Zmora P, Gierer S, Heurich A, Pohlmann S . Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research. Antiviral Res. 2013; 100(3):605-14. PMC: 3889862. DOI: 10.1016/j.antiviral.2013.09.028. View

de Wit E, Munster V . MERS-CoV: the intermediate host identified?. Lancet Infect Dis. 2013; 13(10):827-8. PMC: 4798748. DOI: 10.1016/S1473-3099(13)70193-2. View

Zaki A, van Boheemen S, Bestebroer T, Osterhaus A, Fouchier R . Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012; 367(19):1814-20. DOI: 10.1056/NEJMoa1211721. View

Du L, Zhao G, Kou Z, Ma C, Sun S, Poon V . Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development. J Virol. 2013; 87(17):9939-42. PMC: 3754113. DOI: 10.1128/JVI.01048-13. View

Simmons G, Reeves J, Rennekamp A, Amberg S, Piefer A, Bates P . Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci U S A. 2004; 101(12):4240-5. PMC: 384725. DOI: 10.1073/pnas.0306446101. View

Annan A, Baldwin H, Corman V, Klose S, Owusu M, Nkrumah E . Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe. Emerg Infect Dis. 2013; 19(3):456-9. PMC: 3647674. DOI: 10.3201/eid1903.121503. View

Li F, Li W, Farzan M, Harrison S . Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 2005; 309(5742):1864-8. DOI: 10.1126/science.1116480. View

10.

Li W, Wong S, Li F, Kuhn J, Huang I, Choe H . Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions. J Virol. 2006; 80(9):4211-9. PMC: 1472041. DOI: 10.1128/JVI.80.9.4211-4219.2006. View

11.

Azhar E, El-Kafrawy S, Farraj S, Hassan A, Al-Saeed M, Hashem A . Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med. 2014; 370(26):2499-505. DOI: 10.1056/NEJMoa1401505. View

12.

Heald-Sargent T, Gallagher T . Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence. Viruses. 2012; 4(4):557-80. PMC: 3347323. DOI: 10.3390/v4040557. View

13.

Qian Z, Dominguez S, Holmes K . Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation. PLoS One. 2013; 8(10):e76469. PMC: 3789674. DOI: 10.1371/journal.pone.0076469. View

14.

Zhao G, Du L, Ma C, Li Y, Li L, Poon V . A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV. Virol J. 2013; 10:266. PMC: 3765664. DOI: 10.1186/1743-422X-10-266. View

15.

Chu D, Poon L, Gomaa M, Shehata M, Perera R, Zeid D . MERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis. 2014; 20(6):1049-53. PMC: 4036765. DOI: 10.3201/eid2006.140299. View

16.

Tamai M, Matsumoto K, Omura S, Koyama I, Ozawa Y, Hanada K . In vitro and in vivo inhibition of cysteine proteinases by EST, a new analog of E-64. J Pharmacobiodyn. 1986; 9(8):672-7. DOI: 10.1248/bpb1978.9.672. View

17.

Lu G, Hu Y, Wang Q, Qi J, Gao F, Li Y . Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature. 2013; 500(7461):227-31. PMC: 7095341. DOI: 10.1038/nature12328. View

18.

Li F . Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections. J Virol. 2008; 82(14):6984-91. PMC: 2446986. DOI: 10.1128/JVI.00442-08. View

19.

Cassel J, Blass B, Reitz A, Pawlyk A . Development of a novel nonradiometric assay for nucleic acid binding to TDP-43 suitable for high-throughput screening using AlphaScreen technology. J Biomol Screen. 2010; 15(9):1099-106. PMC: 3426361. DOI: 10.1177/1087057110382778. View

20.

Tao X, Hill T, Morimoto C, Peters C, Ksiazek T, Tseng C . Bilateral entry and release of Middle East respiratory syndrome coronavirus induces profound apoptosis of human bronchial epithelial cells. J Virol. 2013; 87(17):9953-8. PMC: 3754134. DOI: 10.1128/JVI.01562-13. View